Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 30 holding rows worth $147,603,000.

Accession
0001144204-15-008848
Filed
2015-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 30 entries on the cover page, a total value of $147,603,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $147,603,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMICUS THERAPEUTICS INC03152W109COM2,824,185$23,497,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS83,800$12,418,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK87,500$10,720,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM1,134,578$10,654,000thousands by filing date
AGENUS INC00847G705COM NEW2,638,071$10,473,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK910,100$9,165,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM330,635$9,003,000thousands by filing date
MACROGENICS INC556099909COM162,500$5,699,000thousands by filing date
ONCOTHYREON INC682324108COM2,991,636$5,684,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM220,000$5,069,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2246,499$4,548,000thousands by filing date
IGI LABORATORIES INC449575109COM462,342$4,069,000thousands by filing date
CELGENE CORP151020104COM150,000$3,924,000thousands by filing datecall
ARROWHEAD RESEARCH CORP042797209COM525,000$3,875,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON214,805$3,680,000thousands by filing date
IGNYTA INC451731103COM521,233$3,570,000thousands by filing date
ALIMERA SCIENCES INC016259103COM674,593$3,389,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW199,332$3,361,000thousands by filing date
VERICEL CORP92346J108COM1,058,820$3,219,000thousands by filing date
EXELIXIS INC30161QAC8NOTE 4.250% 8/14,250,000$2,398,000thousands by filing dateprincipal
BIOLASE INC090911108COMMON STOCK784,500$2,063,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK300,000$1,779,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM550,670$1,635,000thousands by filing date
Innocoll45780Q103SPONDS ADR225,000$1,335,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR50,000$1,042,000thousands by filing date
HERON THERAPEUTICS INC427746102COM65,900$663,000thousands by filing date
BIOTA PHARMACEUTIALS INC090694100COM258,586$579,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK20,000$82,000thousands by filing dateput
CUBIST PHARMACEUTICALS INC229678123RIGHT 99/99/9999 ADDED141,688$6,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock9,600$4,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-15-008848this filing2015-02-13acceptance time not in the bulk data set